The complement fixation (CF) test is the most commonly used method to detect antibodies against Mycoplasma pneumoniae although other more sensitive techniques, including metabolic inhibition,' indirect immunofluorescence,2 I mycoplasmacidal4 and radioimmunoprecipitation5 tests, have been proposed. The latter methods are, however, timeconsuming and/or require specialised equipment.
Recently, Busolo et al5 and Raisanen et ar have applied the enzyme-linked immunosorbent assay (ELISA) to the diagnosis of Mpneumoniae infection.
Busolo et al have used as antigen an M pneumoniae saline suspension. Their results suggest that ELISA is specific and that its sensitivity lies between those of the metabolic inhibition and radioimmunoprecipitation assays. Raisanen et al, using an antigen obtained by Tween-ether-treatment, have found that ELISA, in contrast with CF test, does not show falsepositive reactions in patients with acute pancreatitis.
In this report, we describe a simple and rapid immunoenzymatic assay performed with commercial protein-antigen and reagents and compare the results obtained by this test with those obtained by convenAccepted for publication 1 September 1982 228 tional CF. We also investigate its suitability for the detection of Mpneumoniae specific IgM antibody.
Material and methods

SERUM SPECIMENS
Two hundred sera obtained from children and adults admitted to Bicetre Hospital were tested. Among them, 117 (group 1) were collected from patients having no respiratory symptoms nor any clinical indication of M pneumoniae infection; 40 (group 2) from patients, with pneumonia, whose paired sera (acute and convalescent phase) had CF titres to M pneumoniae of -32 and no significant rise in CF titres of both samples; 43 (group 3) from patients, with pneumonia, whose sera showed either a fourfold (or greater) rise in CF titre to Mpneumoniae indicating a recent infection, or an unchanged mostly high CF titre (>,64) in both sera, which suggests a possible recent infection.
In addition we tested nine sera (group 4) from six patients with pneumonia (except one, with Reiter's syndrome) who carried M pneumoniae in the throat (except one in the conjunctiva). These sera (kindly supplied by Dr Bonissol, Hospital Necker-Enfants Malades, Paris) had negative or low CF titres to M pneumoniae except for two. Acute and convalescent phase sera were obtained for only three patients and, in these paired sera, antibody titres by CF were stationary.
All sera were inactivated at 56°C for 30 min and stored at -20°C until use.
COMPLEMENT FIXATION TEST
The tests were carried out by Microtitre method using two units of complement, two units of M pneumoniae antigen (purchased from Behring Institut, Behringwerke AG, Marburg) and overnight fixation at 4°C. Sera which gave a reciprocal titre of >8 were recorded as positive.
ELISA PROCEDURE
The tests were performed essentially as described by Voller Figure 1 shows the antibody titres against M pneumoniae of 117 sera obtained from group 1 patients and determined by the CF test and by ELISA using anti-IgG conjugate. Among the sera, 85 (72-6%) gave concordant results with 33 (28.2%) negative and 52 (44-4%) positive by both methods. However, the positive sera had ELISA titres which were usually higher than those by CF. The geometric mean titre was 95*7 by ELISA and 14-3 by CF. No serum was positive by CF and negative by ELISA. In contrast, 32 sera (27.4%) were found to be negative by CF and positive by ELISA. Among the latter, 24 came from adults older than 35 yr, four from oneyear-old children, and four from newborns.
All sera were negative for M pneumoniae specific IgM antibody by ELISA except for four which became negative after latex IgG absorption.
Paired sera from 20 patients of group 2, with CF titres to Mpneumoniae <32 and without a rise in CF titre between both samples, were also tested by ELISA. In all cases, no change in the titre of the sera was detected. As shown in Table 1 , in eight paired sera, no antibody was demonstrated by either test. On the other hand, a significant rise in CF titre to one of the following agents: respiratory syncytial virus (RS), rotavirus, Chlamydia psittaci and parainfluenza virus (type 3), was seen in four of these paired sera. In five patients, the sera which showed low antibody titres by CF were also low by ELISA. In seven cases, the paired samples which were negative by CF, were positive by ELISA (these sera were obtained from adults older than 45 except for two obtained from newborns). None of these 40 sera had detectable Mpneumoniae-specific antibody. group.bmj.com on October 14, 2017 -Published by http://jcp.bmj.com/ Downloaded from positive results in a few instances (2%). However, the ELISA seems to be the most suitable for routine measurement of IgM antibody over other techniques, such as indirect immunofluorescence or radioimmunoassay. Indeed, the estimation of antibody by indirect immunofluorescence is often subjective and radioimmunoassay requires equipment unavailable in many diagnostic laboratories. Furthermore, RF can also interfere with the detection of IgM antibody particularly in indirect immunofluorescence test.'1
In our study, sera from all patients with recent M pneumoniae infection diagnosed on clinical findings and by CF test (group 3 patients) have specific IgM antibody (titre B20). Our results concerning the IgM:IgG ratio in these patients are in agreement with those previously reported2 3 5 12 and confirm the predominance of IgG over IgM in patients over 20 yr.
Two of five patients (group 4) in whom M pneumoniae was detected had no specific IgM antibody by ELISA. In one case, the serum was received the day of the onset of illness and in the other, seven days after. Unfortunately, no convalescent phase sera were obtained from these patients.
The present study in agreement with previous reports3 6 shows that M pneumoniae specific IgM antibody may persist in the patient for up to two months (to 1 year) after infection. Thus the detection of IgM (titre ¢20), in a single serum does not indicate accurately the time of onset of the illness. In contrast, the absence of M pneumoniae IgM antibody in a serum collected 10-20 days after the onset of pneumonia can exclude a current M pneumoniae infection, especially among children. 
